Isbn: 9781032337418 - dermal drug delivery: from innovation to production (18 resultados)

Condición: New.

Condición: New.

Condición: New.

Paperback / softback. Condición: New. New copy - Usually dispatched within 4 working days.

Condición: New.

Condición: New. 1st edition NO-PA16APR2015-KAP.

Condición: As New. Unread book in perfect condition.

Condición: As New. Unread book in perfect condition.

Paperback. Condición: New.

Condición: New.

Condición: New. In English.

Paperback. Condición: Brand New. 464 pages. 9.19x6.13x1.54 inches. In Stock.

Taschenbuch. Condición: Neu. Dermal Drug Delivery | From Innovation to Production | Tapash K. Ghosh | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2022 | CRC Press | EAN 9781032337418 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.…

PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -With the continued advancement of better-quality control and patient outcome reporting systems, changes in the development, control, and regulation of all pharmaceutical delivery systems including transdermal and topical products have been happening on a continuous basis. In light of various quality issues that have been reported by patients and practitioners resulting in the recall or removal of products from the market, both the pharmaceutical industries and regulatory agencies have been adopting new measures to address these issues. With chapters written by experts in this field, this book takes a 21st century multidisciplinary and cross-functional look at these dosage forms to improve the development, design, manufacturing, quality, clinical performance, safety, and regulation of these products.This book offers a wealth of up-to-date information organized in a logical sequence corresponding to various stages of research, development, and commercialization of dermal drug delivery products. The authors have been carefully selected from different sectors of pharmaceutical science for their expertise in their selected areas to present objectively a balanced view of the current state of these products development and commercialization via regulatory approval. Their insights will provide useful information to others to ensure the successful development of the next generation dermal drug products.Key Features:Presents current advancements including new technologies of transdermal and topical dosage forms.Presents challenges in the development of the new generation of transdermal and topical dosage forms.Introduces new technologies and QbD (quality by design) aspects of manufacturing and control strategies.Includes new perspectives on pre-clinical and clinical development, regulatory considerations, safety and quality.Discusses regulatory challenges, gaps, and future considerations for dermal drug delivery systems. 464 pp. Englisch.…

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Tapash K. Ghosh is employed by the Office of Clinical Pharmacology and Biopharmaceutics at CDER, FDA. Before joining the FDA, he held faculty positions in the division of pharmaceutical sciences at the Massachusetts College of Pharmacy i.…

Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - With the continued advancement of better-quality control and patient outcome reporting systems, changes in the development, control, and regulation of all pharmaceutical delivery systems including transdermal and topical products have been happening on a continuous basis. In light of various quality issues that have been reported by patients and practitioners resulting in the recall or removal of products from the market, both the pharmaceutical industries and regulatory agencies have been adopting new measures to address these issues. With chapters written by experts in this field, this book takes a 21st century multidisciplinary and cross-functional look at these dosage forms to improve the development, design, manufacturing, quality, clinical performance, safety, and regulation of these products.This book offers a wealth of up-to-date information organized in a logical sequence corresponding to various stages of research, development, and commercialization of dermal drug delivery products. The authors have been carefully selected from different sectors of pharmaceutical science for their expertise in their selected areas to present objectively a balanced view of the current state of these products development and commercialization via regulatory approval. Their insights will provide useful information to others to ensure the successful development of the next generation dermal drug products.Key Features:Presents current advancements including new technologies of transdermal and topical dosage forms.Presents challenges in the development of the new generation of transdermal and topical dosage forms.Introduces new technologies and QbD (quality by design) aspects of manufacturing and control strategies.Includes new perspectives on pre-clinical and clinical development, regulatory considerations, safety and quality.Discusses regulatory challenges, gaps, and future considerations for dermal drug delivery systems.…